MyFinsight
Home
Blog
About
Back
Income Statement
Oncotelic Therapeutics, Inc. (OTLC)
Oncotelic Therapeutics, Inc. (OTLC)
source: myfinsight.com
Gain on
derecognition of...
$1,100,000
Change in fair value
equity investment
$300,000
Change in fair value of
derivative on debt
$102,868
(-78.75%↓ Y/Y)
Total other income
$1,184,576
(328.55%↑ Y/Y)
Interest expense, net
$318,292
(53.19%↑ Y/Y)
Net income (loss)
before...
$341,011
(62.04%↑ Y/Y)
Net loss
attributable to...
-$47,136
(30.07%↑ Y/Y)
Loss from operations
-$843,565
(-1178.73%↓ Y/Y)
Service revenue
$250,000
Net income (loss)
attributable to oncotelic...
$388,147
(39.69%↑ Y/Y)
Total operating
expenses
$1,093,565
(1557.70%↑ Y/Y)
General and
administrative
$1,093,220
(1564.67%↑ Y/Y)
Research and development
$345
(16.16%↑ Y/Y)
Back